Pfizer,Astra Zeneca interested in Marketing Vascepa
Amarin wants more than 30$/share--but Pfizer is perhaps not sure about the high valuation.
The price target range by 8 analyst is 21.50 to 28$/share.
That is why I think Marketing Partnership is the best option now--especially in markets outside USA.
I have stated before--WL (Warner Lambert)and Pfizer agreed to marketing deal in 1996.It was 1999 that bidding started--with 2 years sales data.Wyeth(Amer.Home Prod.) bid first in 1999.
Proper valuation -fair to all,is only possible with at least 18 months data.They can have 2-3 years marketing deal in the meantime.